Meet
Versius Plus

The next generation in surgical robotics.
Versius Plus is a surgical robot developed and engineered for versatility and adaptability, driven by a digital ecosystem embedded at its core.
Stryker and CMR Surgical Announce Strategic Alliance to Advance Robotic-Assisted Surgery.
quote icon
This strategic alliance is a significant milestone for CMR and a strong endorsement of the technology, clinical experience and global business we have built.

Massimillano Colella
Chief Executive Officer at CMR Surgical

Freedom to Access By Design - Versius Plus

Versius Plus is designed to expand access to robotic surgery

Adaptable

Owing to its compact, modular design, Versius Plus moves easily between departments and operating rooms – with no dedicated OR required. Hospitals can seamlessly switch between robotic and non-robotic procedures in the same space. Surgeons benefit from flexible port placement, choosing the setup that best fits their patient and their technique. 

Versatile

Through design and technology, Versius Plus delivers the precision and efficiency surgeons demand. Its integrated fluorescence visualization system, vLimeLite, enables real-time ICG imaging, delivering enhanced visual information. With the US instrument portfolio, Versius Plus is ready to transform surgical experience in the OR.

Digitally Driven

The Versius Plus ecosystem puts data at your fingertips through two dedicated apps1 for surgeons and hospital teams. Versius Connect provides near-real-time procedural logbook for surgeons, while Versius Team offers live dashboard tracking usage, case volume, and system efficiency. Together, these tools help optimize your robotic program with clear insights.

Learn more about Versius Plus

CMR US Instrument Portfolio
US instrument portfolio
Click for more
Enhanced vision system
Click for more
Digitally driven ecosystem
Click for more

Publications

Ready to experience Versius Plus? Connect with our team today.

News

The CMR Surgical news page keeps you in the know, from updates on Versius and its developments, to the latest in robotic surgery news. We also celebrate our team, welcome new appointments and showcase our corporate wins.

FDA Clears Versius Plus Surgical Robotic System for Specified Benign Gynaecological Procedures

CMR Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Versius Plus Surgical Robotic System in specified benign gynaecological ...
Read more

Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery

Strategic alliance combines CMR Surgical’s established platform and robotics expertise with Stryker’s scale, customer relationships and commercial reach to accelerate growth of the Versius Surgical ...
Read more

CMR Surgical and NVIDIA showcase future of intelligent surgery with Versius Plus™ at SRS 2026

CMR Surgical will demonstrate at SRS 2026, for the first time to a surgical audience, the potential for Versius Plus™ to leverage surgical data to ...
Read more

The Versius Surgical System (Versius Plus) is 510(k) cleared by FDA for cholecystectomy in adult patients 22 years of age and older that are eligible for soft tissue minimal access general surgery and is 510(k) cleared (K261252) for gynecologic surgery for benign total hysterectomy, oophorectomy, salpingectomy, adnexectomy, ovarian cystectomy, and lysis of adhesions. Use of the Monopolar Curved Scissors is contraindicated in gynecologic surgery. The use of Bipolar Graspers, monopolar hook, and non-energized Curved Scissors are recommended for these procedures. For full safety information see the full instructions for use.

Versius Plus is part of a Versius ecosystem comprised of the Versius Surgical System, the EIZO CuratOR product, the vLimeLite visualisation system, and a suite of electrosurgical and non-electrosurgical instruments in the United States.

CMR Surgical, the CMR Surgical logo, vLimeLite and Versius are trademarks or registered trademarks of CMR Surgical in the UK and other jurisdictions. EIZO, the EIZO logo, and CuratOR are trademarks or registered trademarks of EIZO Corporation in Japan and other countries. Indocyanine green (ICG) is a drug and is not provided by CMR Surgical and must be independently sourced by the customer. The approval status of the drug may vary by country.

The Versius System vLimeLite Instructions for Use, including the approved indications, contraindications and warnings can be found in the product labelling supplied with each Versius Plus System. The Ultrasonic Dissector is not approved for sale in the United States. Versius and its associated products are commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. Please contact your local CMR Surgical representative for product availability in your region. Refer to the product-specific user manual for indications, contraindications, warnings, and other product information.

Read the Safety Information.

Footnote 1: Versius Connect and Versius Team are software applications provided to support case logging, education, and operational workflow. They are not medical devices, are not part of the FDA-cleared Versius Plus Surgical System, and are not intended for use in the diagnosis, treatment, or monitoring of patients or to control or operate the Versius Plus Surgical System. Always refer to the Versius Plus Instructions for Use

How can we help you?